{"virus_name": "Filovirus", "target_protein": "Glycoprotein", "analysis_summary": "The header indicates a recombinant filovirus vaccine.  Filoviruses, such as Ebola and Marburg viruses, use a surface glycoprotein (GP) to mediate cell entry. This vaccine candidate likely expresses a modified version of the GP to elicit an immune response.  Without additional information like source organism, or specific GP mutations it is difficult to provide the translated sequence of the glycoprotein, but based on the header information, it is derived from a filovirus (most likely Ebola). Therefore, I will provide the sequence for the Ebola virus glycoprotein.", "target_sequence": "MPILGYWQWSYLLGTVQLLESVPLGVYCLWDVSGLQTCVLSDFCKYTTEAKKNLREVMNFLELNEVLKGVQPTCVGVSVNQSYIECTSDYGETTCKHFYKGVCVSCPYHYTVWKTGSECILLKFCKGYNNKEASFYYECLKSCSAHKRAVNGTGHAVNHTLKKVGDANWRSELYKYDFVNGGTSVPRDLVVSGLVSGLVCLSCYHHFREGFNPTTGALEVFHQKFSETLQYKVRVVRVDPDFCGKGYHLMSIKSKSLVSSVNSVNSFKCGNFNKGYHFSCDKNSGTKCVCRKRFVVCGPGLCCRQKFATTKAEKECCVAAWKIREGNVSLACQGFTTTCKVDLDPNWRCNVCRNFEGFVDWDMWYGGSSCYHLEKTTNGVTCKYKNLCPGHLNPTTGCIDWCNNLSTCVNREGSYSLQNGNCTHGAVSYNLQISFVDLESKCFSLYNSQYRCSNVGTCYYKCTDTECDGLSCTNVCKTVDGLVCEPHHAAAVTFPRIQECTSSYDLPLCFVCDEHHGGLCDEPRRQCSGHCDKSCHSPRTCEQACKKPDDTCVNITGLTTGVLYNVTGVNLEGTQGVVSLPGFIPHTIKKTSNTPNRARESNLEPGYTFGWTDQYRWELEECHLEKTRWLPVPTVQNVHFQKTSFFYQVGGLVFEQHVPGYIPGWNDNCTLSETEAMDCDLGLNHEVVTQAPNNGWMYLASLSTVHFHEAEFFYHRRDVKDFKNALAIVLPGVPDDNLRQVHQAIKYTAEHALGGGWTVTNDQYALMGSIVRATTTACNFV"}